Post by
goldtech on Nov 25, 2022 5:37pm
FDA filing
Soon the filing for PMN310 will be released and phase 1a will start. This will show toxicity and we know by the primate study that it will be negligible. This step will take us to 1B where all the excitement resides. I laugh at those that say to sell because why would they care, the answer is they can't buy back in. Tough luck.
Comment by
DarylTheFrog on Nov 25, 2022 7:09pm
I keep on adding at these levels.I think this will be a great pick ver the next year
Comment by
BottomBroker on Nov 28, 2022 11:21am
Cautiously optimistic that the IND will be filed by year-end. Also interested to see what comes out of the conference in San Francisco this week. Let's all keep our fingers crossed for some real progress over the next year.
Comment by
yureja42 on Nov 27, 2022 1:20am
This post has been removed in accordance with Community Policy